In the NewsAugust 11, 2022Bay Area-based company can help test for monkeypox through blood testingJuly 22, 2022Rapid Diagnostic Methods and Technologies in the Management Of Infectious DiseasesMay 26, 2022How Karius aims to transform the diagnosis of infections with a non-invasive liquid biopsyMarch 23, 2022Metagenomic Sequencing Moves to the ClinicFebruary 25, 2022How This Multi-Million Dollar Startup Could Make It Easier to Identify the Next EpidemicFebruary 24, 2021The Top 25 Biotech CEOs of 2021Load morePress ReleasesAugust 10, 2023Karius Inc. Adds Dr. Norman Sharpless, Former National Cancer Institute Head, and Elizabeth O’Farrell, Eli Lilly Veteran, to its Board of DirectorsAugust 2, 2023Karius Test®, a Liquid Biopsy for Infectious Diseases, Incorporated into Diagnostics Recommendation in the 2023 Duke-ISCVID Criteria for Infective EndocarditisApril 11, 2023Karius and eGenesis Partner to Help Accelerate Xenotransplantation for Patients in Need of Organ TransplantsJune 9, 2022Karius® Partners with Capstone Health Alliance to Widen Patient Access to Liquid Biopsy Test for Infectious DiseasesDecember 9, 2021Karius Prepares for Further Growth with New Chief Financial Officer, Chief Legal Officer AppointmentsOctober 28, 2021Karius Test Named “Infectious Disease Testing Solution of the Year” at Inaugural 2021 BioTech Breakthrough Awards
May 26, 2022How Karius aims to transform the diagnosis of infections with a non-invasive liquid biopsy
February 25, 2022How This Multi-Million Dollar Startup Could Make It Easier to Identify the Next Epidemic